Last reviewed · How we verify
Liquid oxygen
At a glance
| Generic name | Liquid oxygen |
|---|---|
| Also known as | Liquid medical oxygen |
| Sponsor | Belfast Health and Social Care Trust |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis (NA)
- Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission (PHASE3)
- Effect of FFP2 Masks on Peripheral Oxygen Saturation and Pulse Rate During the COVID-19 Pandemic
- Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery (NA)
- Effects of Treatments on Atopic Dermatitis (PHASE2)
- Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels (PHASE2)
- Siplizumab for Sickle Cell Disease Transplant (PHASE1, PHASE2)
- Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Liquid oxygen CI brief — competitive landscape report
- Liquid oxygen updates RSS · CI watch RSS
- Belfast Health and Social Care Trust portfolio CI